In recent years, marathon running has surged in popularity as a test of human endurance and fitness. Yet, its effects on the heart, particularly whether these represent beneficial adaptations or potential harm, remain enigmatic. A comprehensive synthesis published in BMJ Open Sport & Exercise Medicine sought to unravel the acute cardiac responses triggered by marathon running, bringing into focus the complexities tied to age, sex, and training status. The study underscores a nuanced balance between transient physiological changes and possible early signs of long-term cardiac stress.
Endurance exercise like marathon running imposes remarkable hemodynamic demands on the cardiovascular system. It is well documented that vigorous physical activity temporarily elevates biomarkers indicative of myocardial stress or injury. However, distinguishing normal transient elevations from pathological signals is crucial. This meta-analysis integrated data from a myriad of studies published until April 2025, encompassing over 3,200 predominantly male runners aged between 27 and 63. The researchers collated evidence focusing primarily on cardiac biomarkers, echocardiographic parameters, and cardiac MRI assessments conducted immediately before and after marathon events.
Central to the investigation were three biomarkers: cardiac troponin T (cTnT), cardiac troponin I (cTnI), and N-terminal proB-type natriuretic peptide (NT-proBNP). These molecular indicators are widely recognized in clinical cardiology for reflecting myocardial injury, ischemic stress, and ventricular wall strain, respectively. The meta-analysis reinforced that all three biomarkers experience significant elevations within the first hour post-marathon, frequently surpassing clinical thresholds commonly utilized to signal myocardial infarction or heart failure in acute care settings. This explosive biomarker response, however, does not necessarily connote irreversible damage.
Echocardiographic evaluations revealed modest, albeit statistically significant, alterations in cardiac chamber dimensions and left ventricular ejection fraction (LVEF) following marathon completion. LVEF, which quantifies the efficiency of blood ejection from the left ventricle, displayed transient fluctuations but largely remained within clinically acceptable ranges. These subtle functional shifts mirror an acute, physiological modulation of cardiac performance in response to the extreme demands of sustained endurance exercise rather than overt dysfunction.
Moreover, cardiac MRI findings bolstered the conclusion that marathon running does not consistently induce structural myocardial injury detectable via imaging. Parameters such as myocardial fibrosis, edema, or infarction, typically discernible through advanced MRI techniques, were conspicuously absent in the cohorts analyzed. This absence of structural pathology suggests that the heart undergoes reversible physiological adaptations rather than permanent damage during these events.
Intriguingly, analyses demonstrated that biomarker elevations and echocardiography-derived functional changes were not uniform but varied in relation to runners’ finishing times, training level, age, and sex. Faster runners and those with higher training loads tended to exhibit pronounced biomarker increases, whereas older athletes displayed distinct cardiac responses. The noticeable underrepresentation of female participants highlights a critical gap, as sex-specific cardiovascular differences might influence both acute and chronic cardiac adaptations to marathon running.
Notwithstanding these insights, the researchers candidly acknowledged important methodological limitations. Primarily, the overwhelming majority of participants were men, limiting the generalizability of findings to women. Moreover, the inconsistency in reporting training status across studies hindered stratified analyses, obscuring potential variation linked to fitness levels. High risk of bias in many included studies also points to the necessity for rigorously designed prospective investigations with standardized protocols and larger, more diverse cohorts.
The clinical implications remain ambiguous. Elevation of cardiac biomarkers post-exercise is well-documented in athletes and is often interpreted as a normal physiological phenomenon reflecting increased membrane permeability or transient myocardial stress. However, the possibility that repetitive episodes might initiate maladaptive remodeling or subtle pathological changes cannot be excluded. These results underscore an urgent need for longitudinal studies capable of tracking the long-term cardiac health of endurance athletes, with particular attention to vulnerable populations and repeated extreme exertion.
This meta-analytic review ultimately harmonizes prior fragmented observations and confirms that marathon running precipitates immediate elevations in canonical biomarkers of cardiac stress while inducing nuanced, temporary alterations in cardiac function. Importantly, these changes do not correspond to structural myocardial injury detectable by current imaging methods. Yet, the study highlights an enduring uncertainty regarding the fine line separating beneficial cardiac adaptations from insidious maladaptive processes triggered by intense endurance exercise.
Experts in cardiovascular physiology and sports medicine emphasize that understanding these acute cardiac responses is fundamental to developing evidence-based exercise guidelines tailored for different demographics and training levels. It also underlines the imperative for personalized risk assessments in athletes contemplating frequent participation in extreme endurance events. This emerging data enables clinicians to better contextualize biomarker elevations and functional changes observed in marathon runners, avoiding unnecessary alarm while maintaining vigilance against potential adverse outcomes.
By calls of this study, future research must prioritize inclusion of women, ethnically diverse populations, and stratification based on precise training metrics. The integration of cutting-edge imaging modalities and molecular profiling over extended follow-up periods will be paramount to elucidate whether post-marathon cardiac changes herald adaptive physiological remodeling or early pathological signs. Only through such comprehensive inquiry can the cardiovascular safety and optimal performance strategies in marathon running be definitively determined.
In conclusion, while marathon running imparts acute and measurable changes to the heart indicative of significant physiological stress, current evidence does not definitively classify these as harmful. The delicate interplay between transient biomarker surges, minor functional shifts, and the absence of structural damage paints a complex picture. Runners, trainers, and healthcare providers must weigh these findings carefully but remain watchful for emerging data that might shed light on the long-term cardiac consequences of repeated endurance exertion.
Subject of Research: People
Article Title: Acute effects of marathon running on the heart: a systematic review and meta-analysis
News Publication Date: 9-Jun-2026
Keywords: Heart, Physical exercise, Marathon running, Cardiac biomarkers, Cardiac function, Echocardiography, Cardiac MRI, Endurance exercise, Cardiac troponin, NT-proBNP, Left ventricular ejection fraction, Cardiovascular adaptations
Tags: acute myocardial stress from endurance exerciseage differences in marathon heart impactcardiac biomarkers in marathon runnerscardiac MRI findings in marathon athletescardiac troponin I elevation post-marathoncardiac troponin T and marathon stressechocardiographic changes from marathon runninglong-term cardiac adaptations to marathon runningmarathon running cardiac effectsNT-proBNP levels after endurance runningsex-specific cardiac response to endurance exercisetraining level influence on marathon heart health
